Federal Register / Vol. 76, No. 159 / Wednesday, August 17, 2011 / Notices 51035 

physical substances, or mixtures 

(collectively referred to as ‘‘substances’’) 

cause adverse health effects and 

provides opinions on whether these 

substances may be of concern given 

what is known about current human 

exposure levels. Assessments of 

potential adverse effects of 

environmental substances on 

reproduction or development carried 

out by CERHR from 1998–2010 are now 

conducted by OHAT. OHAT also 

organizes workshops or state-of-thescience evaluations to address issues of 

importance in environmental health 

sciences. OHAT assessments are 

published as NTP Monographs. 

Information about OHAT is found 

http://ntp.niehs.nih.gov/go/ohat. 

NTP panels are technical, scientific 

advisory bodies established on an ‘‘as 

needed’’ basis to provide independent 

scientific peer review and advise the 

NTP on agents of public health concern, 

new/revised toxicological test methods, 

or other issues. These panels help 

ensure transparent, unbiased, and 

scientifically rigorous input to the 

program for its use in making credible 

decisions about human hazard, setting 

research and testing priorities, and 

providing information to regulatory 

agencies about alternative methods for 

toxicity screening. The NTP welcomes 

nominations of scientific experts for 

upcoming panels. Scientists interested 

in serving on an NTP panel should 

provide a current curriculum vitae to 

Dr. Lori White (see ADDRESSES). The 

authority for NTP panels is provided by 

42 U.S.C. 217a; section 222 of the Public 

Health Service (PHS) Act, as amended. 

The panel is governed by the Federal 

Advisory Committee Act, as amended 

(5 U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

advisory committees. 

Dated: August 8, 2011. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2011–20958 Filed 8–16–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from Sandia National 

Laboratories in Albuquerque, New 

Mexico, as an addition to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. On 

July 29, 2011, the Secretary of HHS 

designated the following class of 

employees as an addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and its 

contractors and subcontractors who worked 

in any area at the Sandia National 

Laboratories in Albuquerque, New Mexico, 

from January 1, 1949 through December 31, 

1962, for a number of work days aggregating 

at least 250 work days, occurring either 

solely under this employment, or in 

combination with work days within the 

parameters established for one or more other 

classes of employees in the Special Exposure 

Cohort. 

This designation will become 

effective on September 9, 2011, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 877– 

222–7570. Information requests can also 

be submitted by e-mail to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2011–20925 Filed 8–16–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–11–08AJ] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 or send 

comments to CDC Reports Clearance 

Officer, 1600 Clifton Road, MS–D74, 

Atlanta, GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Focus Group Testing to Effectively 

Plan and Tailor Cancer Prevention and 

Control Communication Campaigns 

(OMB No. 0920–0800, exp. 1/31/2012)— 

Extension—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The mission of the CDC’s Division of 

Cancer Prevention and Control (DCPC) 

is to reduce the burden of cancer in the 

United States through cancer 

prevention, reduction of risk, early 

detection, better treatment, and 

improved quality of life for cancer 

survivors. Toward this end, the DCPC 

supports the scientific development, 

implementation, and evaluation of 

various health communication 

campaigns with an emphasis on specific 

cancer burdens. This process requires 

testing of messages, concepts, and 

materials prior to their final 

development and dissemination, as 

described in the second step of the 

health communication process, a 

scientific model developed by the U.S. 

Department of Health and Human 

Services’ National Cancer Institute to 

guide sound campaign development. 

CDC is currently approved to collect 

information for these purposes (OMB 

No. 0920–0800, exp. 1/31/2012). A 

three-year extension of the existing 

generic approval is requested. 

The communication literature 

supports various data collection 

methods to conduct credible formative, 


Emcdonald on DSK2BSOYB1PROD with NOTICES
51036 Federal Register / Vol. 76, No. 159 / Wednesday, August 17, 2011 / Notices 

concept, message, and materials testing, 

one of which is focus groups. The 

purpose of focus groups is to ensure that 

the public and other key audiences, like 

health professionals, clearly understand 

cancer-specific information and 

concepts, are motivated to take the 

desired action, and do not react 

negatively to the messages. 

Information collection will involve 

focus groups to assess numerous 

qualitative dimensions of cancer 

prevention and control messages, 

including, but not limited to, 

knowledge, attitudes, beliefs, behavioral 

intentions, information needs and 

sources, and compliance to 

recommended screening intervals. 

Insights gained from the focus groups 

will assist in the development and/or 

refinement of future campaign messages 

and materials. Respondents will include 

health care providers as well as 

members of the general public. 

Communication campaigns will vary 

according to the type of cancer, the 

qualitative dimensions of the message 

described above, and the type of 

respondents. DCPC has developed a set 

of example questions that can be 

tailored to screen for targeted groups of 

respondents, and a set of example 

questions that can be used to develop 

discussion guides for a variety of focus 

groups. 

The average burden for each focus 

group discussion will be two hours. 

DCPC will conduct or sponsor up to 72 

focus groups per year over a three-year 

period. An average of 12 respondents 

will participate in each focus group 

discussion. A separate information 

collection request will be submitted to 

OMB for approval of each focus group 

activity. 

There are no costs to respondents 

except their time. The total estimated 

annualized burden hours are 1,814. 

Estimated Annualized Burden Hours: 

Type of respondents Form name Number of respondents 

Number of responses per 

respondent 

Average burden per response (in 

hours) 

Total burden 

(in hours) 

Health care providers and general 

public.

Screening Form ................................ 1,728 1 3/60 86 

Focus Group Discussion Guide ....... 864 1 2 1728 

Total ........................................... ........................................................... ........................ ........................ ........................ 1814 

Dated: August 10, 2011. 

Daniel Holcomb, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2011–20920 Filed 8–16–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–11–0802] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Daniel Holcomb, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS–D74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Active Bacterial Core Surveillance 

(ABCs) Projects—OMB 0920–0802, 

Expiration January 31, 2012 

(Revision)—National Center for 

Immunization and Respiratory Disease 

(NCIRD), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

CDC is requesting a revision to the 

approved data collection instruments 

for Active Bacterial Core surveillance 

(ABCs), to add supplemental questions 

for invasive methicillin-resistant 

Staphylococcus aureus (MRSA). CDC 

requests OMB approval to collect 

supplemental information to assess risk 

factors for invasive MRSA among 

patients recently discharged from acute 

care hospitals. Seventeen acute care 

facilities in 7 ABCs/EIP sites (CA, CT, 

CO, GA, NY, MN, TN) will participate 

in the collection of supplemental 

information for ABCs MRSA. 

Preventing healthcare-associated 

invasive MRSA infections is one of 

CDC’s priorities. Essential steps in 

reducing the occurrence of healthcareassociated invasive MRSA infections are 

to quantify the burden and to identify 

modifiable risk factors associated with 

invasive MRSA disease. The current 

ABCs MRSA surveillance has been 

essential to quantify the burden of 

invasive MRSA in the United States. 

Through this surveillance CDC was able 

to estimate that 94,360 invasive MRSA 

infections associated with 18,650 deaths 

occurred in the United States in 2005. 

The majority of these infections (58%) 

had onset in the community or within 

3 days of hospital admission and 

occurred among individuals with recent 

healthcare exposures (healthcareassociated community-onset [HACO]). 

More recent data from the CDC’s EIP/ 

ABCs system have shown that two 

thirds of invasive HACO MRSA 

infections occur among persons who are 

discharged from an acute care hospital 

in the prior 3 months. Risk factors for 

invasive MRSA infections postdischarge have not been well evaluated, 

and effective prevention measures in 

this population remain uncertain. 

The goal of the supplemental 

questions to be added to ABCs MRSA 

surveillance is to assess risk factors for 

invasive healthcare-associated MRSA 

infections, which will inform the 

development of targeted prevention 

measures. This activity supports the 

HHS Action Plan for elimination of 

healthcare-associated infections. This 

change will result in minimal impact on 

the current public burden. 


Emcdonald on DSK2BSOYB1PROD with NOTICES